106 related articles for article (PubMed ID: 25452171)
1. Prognostic value of differential CCND1 expression in patients with resected gastric adenocarcinoma.
Ma L; Wang X; Lan F; Yu Y; Ouyang X; Liu W; Xie F; Huang Q
Med Oncol; 2015 Jan; 32(1):338. PubMed ID: 25452171
[TBL] [Abstract][Full Text] [Related]
2. Elevated nuclear CCND1 expression confers an unfavorable prognosis for early stage lung adenocarcinoma patients.
Xu P; Zhao M; Liu Z; Liu Y; Chen Y; Luo R; Fang W
Int J Clin Exp Pathol; 2015; 8(12):15887-94. PubMed ID: 26884860
[TBL] [Abstract][Full Text] [Related]
3. High Tumor Vascular Endothelial Growth Factor Expression Is Associated With Poorer Clinical Outcomes in Resected T3 Gastric Adenocarcinoma.
Lin C; Zhang Z; Xu Y; Wang R; Chen S; Gao J; Wang D; Huang Q; Tu X; Wang L
Am J Clin Pathol; 2016 Sep; 146(3):278-88. PubMed ID: 27543975
[TBL] [Abstract][Full Text] [Related]
4. SNP rs1059234 in CDKN1A Gene Correlates with Prognosis in Resected Gastric Adenocarcinoma.
Nie X; Wang X; Lin Y; Yu Y; Liu W; Xie F; Wang X; Tan J; Huang Q
Clin Lab; 2016; 62(3):409-16. PubMed ID: 27156331
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic significance of melatonin receptor MT1 in patients with gastric adenocarcinoma.
Wang XT; Chen CW; Zheng XM; Wang B; Zhang SX; Yao MH; Chen H; Huang HF
Neoplasma; 2020 Mar; 67(2):415-420. PubMed ID: 31829023
[TBL] [Abstract][Full Text] [Related]
6. Activation of FOXO3a suggests good prognosis of patients with radically resected gastric cancer.
Yu S; Yu Y; Sun Y; Wang X; Luo R; Zhao N; Zhang W; Li Q; Cui Y; Wang Y; Li W; Liu T
Int J Clin Exp Pathol; 2015; 8(3):2963-70. PubMed ID: 26045805
[TBL] [Abstract][Full Text] [Related]
7. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer.
Hu M; Li K; Maskey N; Xu Z; Yu F; Peng C; Li Y; Yang G
Hum Pathol; 2015 Dec; 46(12):1872-80. PubMed ID: 26434630
[TBL] [Abstract][Full Text] [Related]
9. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.
Wilke H; Muro K; Van Cutsem E; Oh SC; Bodoky G; Shimada Y; Hironaka S; Sugimoto N; Lipatov O; Kim TY; Cunningham D; Rougier P; Komatsu Y; Ajani J; Emig M; Carlesi R; Ferry D; Chandrawansa K; Schwartz JD; Ohtsu A;
Lancet Oncol; 2014 Oct; 15(11):1224-35. PubMed ID: 25240821
[TBL] [Abstract][Full Text] [Related]
10. Lin28B is a novel prognostic marker in gastric adenocarcinoma.
Hu Q; Peng J; Liu W; He X; Cui L; Chen X; Yang M; Liu H; Liu S; Wang H
Int J Clin Exp Pathol; 2014; 7(8):5083-92. PubMed ID: 25197381
[TBL] [Abstract][Full Text] [Related]
11. Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability.
Cho J; Lee J; Bang H; Kim ST; Park SH; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kang WK; Kim S; Kim KM
Oncotarget; 2017 Feb; 8(8):13320-13328. PubMed ID: 28076847
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of ERCC1 mRNA expression in non-small cell lung cancer, breast cancer, and gastric cancer in patients from Southern China.
Deng Q; Yang H; Lin Y; Qiu Y; Gu X; He P; Zhao M; Wang H; Xu Y; Lin Y; Jiang J; He J; Zhou JX
Int J Clin Exp Pathol; 2014; 7(12):8312-21. PubMed ID: 25674197
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of
Knief J; Reddemann K; Lazar-Karsten P; Herhahn T; Petrova E; Wellner U; Thorns C
J Clin Pathol; 2017 Mar; 70(3):274-276. PubMed ID: 28011578
[No Abstract] [Full Text] [Related]
14. Various ARID1A expression patterns and their clinical significance in gastric cancers.
Kim YB; Ham IH; Hur H; Lee D
Hum Pathol; 2016 Mar; 49():61-70. PubMed ID: 26826411
[TBL] [Abstract][Full Text] [Related]
15. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
[TBL] [Abstract][Full Text] [Related]
16. Inorganic pyrophosphatase (PPA1) is a negative prognostic marker for human gastric cancer.
Yang Y; Cai J; Yin J; Wang D; Bai Z; Zhang J; Wang K; Yu G; Zhang Z
Int J Clin Exp Pathol; 2015; 8(10):12482-90. PubMed ID: 26722435
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
Wang CY; Hua L; Yao KH; Chen JT; Zhang JJ; Hu JH
Int J Clin Exp Pathol; 2015; 8(1):779-85. PubMed ID: 25755774
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of Ras-GTPase-activating protein SH3 domain-binding protein 1 correlates with poor prognosis in gastric cancer patients.
Min L; Ruan Y; Shen Z; Jia D; Wang X; Zhao J; Sun Y; Gu J
Histopathology; 2015 Nov; 67(5):677-88. PubMed ID: 25809930
[TBL] [Abstract][Full Text] [Related]
19. Decreased LIPF expression is correlated with DGKA and predicts poor outcome of gastric cancer.
Kong Y; Zheng Y; Jia Y; Li P; Wang Y
Oncol Rep; 2016 Oct; 36(4):1852-60. PubMed ID: 27498782
[TBL] [Abstract][Full Text] [Related]
20. Cadherin 5 expression correlates with poor survival in human gastric cancer.
Higuchi K; Inokuchi M; Takagi Y; Ishikawa T; Otsuki S; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2017 Mar; 70(3):217-221. PubMed ID: 27466381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]